Avalo Therapeutics, Inc. · NASDAQ:AVTX

Millennium Management LLC's stake in Avalo Therapeutics, Inc. fell to 4.90% (Schedule 13G)

Event Jan 28, 2026 · Filed Feb 3, 2026

Millennium Management LLC's stake in Avalo Therapeutics, Inc. fell to 4.90%, 905,798 shares, as a passive investor on Jan 28, 2026. Filed Feb 3, 2026 (Schedule 13G).

Stake
4.90%
Shares
905,798
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Millennium Management LLC4.90%905,798
Millennium Group Management LLC4.90%905,798
Israel A. Englander4.90%905,798

Source

View original at SEC

Related